Breast Biopsy is removal of cells or tissues from doubtful areas of breast. These cells or tissues are studied under a microscope to verify the presence of cancer. When a hollow needle is used to remove tissue samples from breast, it is known as core needle biopsy. It is the typical way to rule out or diagnose breast cancer. Core needle biopsy is done for the palpable mass or lump that can be felt, or suspicious area which is seen after mammogram or imaging test.
Read Report Overview – https://www.transparencymarketresearch.com/needle-aspiration-biopsy-market.html
Fine needle biopsy, also known as fine needle aspiration, removes the cells from suspicious lump in breast. The needle used for fine needle biopsy is thinner than the needle used for core needle biopsy. According to the American Cancer Society, 252,710 new cases of invasive breast cancer are projected to be diagnosed in women in the U.S. in 2017. About 63,410 new cases of carcinoma in situ (CIS) are anticipated to be diagnosed (CIS is non-invasive and is the earliest form of breast cancer). About 40,610 women are expected to die from breast cancer.
Different types of biopsies are core needle biopsy, fine needle aspiration biopsy, vacuum-assisted biopsy, image-guided biopsy, incisional biopsy, excisional biopsy, shave biopsy, punch biopsy, endoscopic biopsy, and bone marrow aspiration & biopsy. Two major types of biopsies are needle biopsy and surgical biopsy. Needle biopsy involves usage of a needle to remove tissue sample. Surgical biopsy involves an incision to collect tissue sample. Core needle biopsy is done in imaging centers or hospitals. It is an image guided biopsy procedure.
Request Brochure of Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=35909
Advantages of core needle biopsy and fine needle biopsy are least chance of bruising or infection. If the lump is confirmed benign, then surgical biopsy is not required. However, there is a chance that the needle may miss the tumor cells, and hence misinterpret it as non-cancerous cell. Fine needle aspiration has false negative rate of 2% to 4%. Hence, fine needle aspiration can be followed by core needle biopsy or surgical biopsy.
Based on utility, the global needle aspiration biopsy market can be categorized into disposable and reusable. In terms of application, the market can be segmented into tumor, inflammation, infection, and others. Based on end-user, the global needle aspiration biopsy market can be classified into diagnostic & imaging centers, hospitals, academics & research centers, and others.
Request for Custom Research – https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=35909
Increase in prevalence and incidence of cancer globally and rise in awareness about diseases are the major factors fueling the growth of the global needle aspiration biopsy market. However, technological advancements in imaging such as computed tomography and magnetic resonance imaging are likely to restrain the global needle aspiration biopsy market. Emergence of fluid biopsy can also hamper the growth of the market.
The global needle aspiration biopsy market can be segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Asia Pacific is projected to reflect a high CAGR due to significant patient population. Growing awareness among patients as well as health care professionals has led to increase in number of diagnosed cases of cancer in Asia, especially in China and India. North America is projected to dominate the global needle aspiration biopsy market due to factors such as rise in number of reported cancer cases, high per capita health expenditure, and significant investment in R&D for effective treatment alternatives.
Pre Book Needle Aspiration Biopsy Market Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=35909<ype=S
Key players in the global needle aspiration biopsy market include Cook Medical, Boston Scientific Corporation, Hologic, Inc., Medax Srl Unipersonale, Cardinal Health, Inc., C. R. Bard, Inc., Becton, Dickinson and Company, Leica Biosystems Nussloch GmbH, Möller Medical GmbH, Hakko Co. Ltd., Argon Medical Devices, Inc., and COMPASS International Innovations, Inc.
Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
USA – Canada Toll Free: 866-552-3453